Research graph
References from Reply to Riccardo Lombardo’s Letter to the Editor re: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.06.020. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.eururo.2026.06.020
10.1016/j.eururo.2026.06.020 · External reference
A novel prediction tool based on multiparametric magnetic resonance imaging to determine the biopsy strategy for clinically significant prostate cancer in patients with PSA levels less than 50 ng/ml
10.1245/s10434-019-08111-2 · 2020 · External reference
Microultrasonography-Guided vs MRI-guided biopsy for prostate cancer diagnosis: the OPTIMUM randomized clinical trial
10.1001/jama.2025.3579 · 2025 · External reference
The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies
10.1016/j.eururo.2018.11.040 · 2019 · External reference
10.1016/j.eururo.2026.08.026 · Admitted local publication
ProBIOPSY: a multidisciplinary international consensus on standards for prostate biopsy
10.1016/j.eururo.2026.06.012 · 2026 · External reference
